Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient

NCT03159832 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency,Type 2 Diabetes

Interventions

DRUG: SHR3824

Sponsor

Jiangsu HengRui Medicine Co., Ltd.